Charles Schwab Investment Management Inc Abeona Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 23,850 shares of ABEO stock, worth $137,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,850
Previous 23,850
-0.0%
Holding current value
$137,853
Previous $150,000
12.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABEO
# of Institutions
69Shares Held
28.7MCall Options Held
631KPut Options Held
2.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$22.6 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$21.3 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$20.4 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$12.2 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$12 Million7.9% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $34.4M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...